Respiratory syncytial virus (RSV) is a significant health risk, often mistaken for a common cold, that can lead to severe illness and death. According to the Australian Medical Association (AMA), recent data shows that maternal vaccination has helped reduce RSV cases in young children by over 9 percent, dropping from 86,000 cases in 2024 to 78,000 in 2025.
Why RSV Protection Matters for Vulnerable Groups
While many people brush off RSV as a minor winter nuisance, the medical reality is far more serious. For babies, older Australians, and high-risk individuals, the virus is a major threat. According to the AMA, RSV was the third most common cause of respiratory viral infection hospitalisations among older adults last year, with 587 deaths in Australia involving the virus.
AMA President Dr. Danielle McMullen emphasizes that complacency is the biggest hurdle. "Too many people still think RSV is just a bad cold, but for some Australians it can be far more serious than that," Dr. McMullen noted. The virus does not just cause discomfort; it can lead to hospitalisation and death, making awareness during RSV Awareness Week a vital public health effort.
How Vaccination Trends Are Changing Outcomes
The introduction of targeted vaccines has already begun to shift the landscape of respiratory health. Since February 2024, more than 225,000 mothers have received the maternal RSV vaccine. This effort has provided critical protection to newborns during their first months of life, directly contributing to the drop in cases among young children seen over the past year.
Looking forward, the federal government has expanded the National Immunisation Program to include further coverage. As of 15 May 2026, people aged 75 and over, as well as Aboriginal and Torres Strait Islander people aged 60 and over, are eligible for funded RSV vaccination.
Did you know? The maternal RSV vaccine is specifically designed to pass antibodies to the baby, providing protection during the most vulnerable early months of life.
The Role of General Practice in Vaccine Confidence
Navigating vaccine decisions can be complex, and the AMA advocates for a personal, evidence-based approach. Through the "Have the Jab Chat" campaign, the organisation encourages patients to bypass generic online information and speak directly with their GP.
"Your GP can explain what is recommended for you, including whether RSV vaccination should be part of your winter protection plan," Dr. McMullen stated. Unlike retail settings, general practices offer a space for medically supervised, patient-centred care where individuals can discuss specific concerns about flu, COVID-19, and RSV vaccines.
Pro Tips for Your Next GP Visit
- Bring your history: Keep a record of previous vaccinations to help your GP tailor your advice.
- Ask about timing: Since RSV is seasonal, ask your doctor about the optimal window for getting vaccinated before peak transmission months.
- Discuss the full suite: Use your appointment to review all recommended immunisations, not just one.
Frequently Asked Questions
Who is currently eligible for a funded RSV vaccine in Australia?
As of 15 May 2026, the National Immunisation Program covers people aged 75 and over, Aboriginal and Torres Strait Islander people aged 60 and over, and eligible pregnant women.
Is RSV just a winter illness?
While often seasonal, RSV remains a year-round health concern that can cause severe respiratory complications. The AMA stresses that it should not be treated with complacency at any time of year.
Where is the best place to get vaccinated?
The AMA recommends general practice, as GPs provide medically supervised services and are best equipped to discuss vaccine advice tailored to your individual health circumstances.
Have you spoken to your GP about your winter protection plan? Join the conversation in the comments below or visit the Have the Jab Chat website to learn more about how to protect yourself and your family.
